ArticleScientific reports2025
The multivariate shared truncated normal frailty model with application to medical data.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
A new multivariate shared frailty model based on the truncated normal distribution is proposed. For the basal distribution of failure times, we assume a parametric approach through the Weibull and piecewise exponential distributions and also a nonparametric approach. Similar to the traditional gamma frailty model, the Laplace transform, the hazard and survival functions of our proposal have a simple and closed form. In addition, the n-th derivative of the Laplace transform can be expressed recursively. Parameter estimation is performed by a classical approach through the EM algorithm. A simulation study is presented to demonstrate the consistency of the estimators in finite samples. Finally, two applications to medical data modelling the recurrence of infection in renal patients and patients with fibrosarcoma are presented to demonstrate the effectiveness of the model compared to other classical approaches in the literature. The computational implementation of the model is available in the extrafrail package of R.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.